Merck Partners with Rigaku to Develop Novel Molecular Structure Analysis Technology

摘要

Merck,a leading science and technology company,and Rigaku Corporation,a key player in scientific analytical instrumentation,have signed a joint development agreement to develop lab consumables based on highly innovative crystalline sponge technology,which determines the absolute chemical structure of organic molecules and enables X-ray crystallography without crystallisation of the analyte."Rigaku has been at the leading edge of technology in the high-end crystallography market for decades.This project will open new doors for scientists at all levels of expertise across a range of disciplines-in medicine,life science and the evolution of advanced materials,"said Yoshiaki Watanabe,Senior Executive VP at Rigaku.